Meche, A., Aubrac, C., Johnson, S. M., Hlavacek, P., Hughes, D., Nador, G., Yadav, C. P., Dibonaventura, M., Chen, Y. (2025). Real-world characteristics of patients initiating elranatamab for relapsed/refractory multiple myeloma in the United States. Blood. https://doi.org/10.1182/blood-2025-8144